Cognitive Peptides: Selank vs. Dihexa

The Nootropic Peptide Landscape

Cognitive enhancement is one of the fastest-growing areas of peptide research. While dozens of compounds show some level of neurological activity, two peptides have emerged as the most studied and most distinct in their approaches: Selank and Dihexa.

They both support cognitive function, but they do it through entirely different mechanisms — making them interesting to compare and, for some researchers, to study together.

Selank: The Anxiolytic Nootropic

Origins

Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It's a synthetic analogue of tuftsin, a naturally occurring immunomodulatory peptide. Selank extends tuftsin's four-amino-acid sequence with three additional residues for improved stability.

Mechanism of Action

Selank's cognitive effects operate through several pathways:

BDNF Modulation Selank increases expression of brain-derived neurotrophic factor (BDNF) — a protein critical for neuroplasticity, memory formation, and neuronal survival. Higher BDNF levels are associated with improved learning and cognitive resilience.

GABAergic System Selank modulates GABA receptor activity, producing anxiolytic (anti-anxiety) effects without the sedation associated with benzodiazepines. This is key to its profile: it calms without dulling.

Serotonin Metabolism Research shows Selank influences serotonin and its metabolites in the brain, contributing to mood stabilization and emotional regulation.

Research Highlights

• Reduced anxiety scores in clinical studies without sedative side effects
• Enhanced memory consolidation in animal models of learning
• Improved cognitive performance under stress conditions
• Immune system modulation via IL-6 and T-cell activity

Administration

Selank is administered as a nasal spray — one of the few peptides with this route. Intranasal delivery provides rapid absorption across the nasal mucosa with direct access to the CNS via the olfactory pathway.

• Dose: 250–500mcg per administration
• Frequency: 1–3x daily
• Cycle: 2–4 weeks

Dihexa: The Neurotrophic Powerhouse

Origins

Dihexa was developed at Washington State University by a team studying angiotensin IV analogs. While investigating compounds related to the angiotensin system, they discovered that Dihexa had extraordinary neurotrophic properties — far exceeding expectations.

Mechanism of Action

Dihexa works through a fundamentally different pathway than Selank:

HGF/c-Met Activation Dihexa activates the hepatocyte growth factor (HGF) / c-Met receptor system in the brain. This system is involved in neuronal growth, synaptic formation, and the creation of new neural connections. The activation of HGF/c-Met promotes synaptogenesis — the formation of new synapses between neurons.

Potency In the original research, Dihexa was found to be approximately 10 million times more potent than BDNF at promoting new synaptic connections in cell culture models. This extraordinary potency is due to its mechanism: rather than acting as a growth factor itself, it facilitates the binding of HGF to its receptor, amplifying an existing signaling pathway.

Blood-Brain Barrier Penetration Unlike many peptides, Dihexa crosses the blood-brain barrier effectively after oral administration. This is unusual — most peptides require injection or nasal delivery to reach the CNS.

Research Highlights

• Restored cognitive function in animal models of cognitive impairment
• Promoted new dendritic spine formation (physical basis of memory)
• Effective via oral administration (rare for cognitive peptides)
• Operated through a mechanism independent of traditional nootropic pathways

Administration

Dihexa is taken orally — a significant practical advantage.

• Dose: 10–20mg per day
• Frequency: 1x daily
• Cycle: 4–6 weeks

Head-to-Head Comparison

| Factor | Selank | Dihexa | |--------|--------|--------| | Primary mechanism | BDNF + GABA modulation | HGF/c-Met synaptogenesis | | Cognitive target | Memory + anxiety reduction | Synaptic connectivity + memory | | Anti-anxiety effects | Strong (anxiolytic) | Not primary effect | | Route | Nasal spray | Oral | | Onset | Rapid (minutes to hours) | Gradual (days to weeks) | | Derived from | Tuftsin (immune peptide) | Angiotensin IV (vascular peptide) | | Natural analog | Yes (tuftsin occurs in the body) | No (fully synthetic) | | Research volume | Extensive (Russian clinical studies) | Emerging (primarily preclinical) | | Immune effects | Yes (immunomodulatory) | No |

Different Tools for Different Questions

The distinction between Selank and Dihexa maps to two different approaches to cognitive enhancement:

Selank optimizes the existing system. It reduces anxiety that interferes with cognitive performance, supports BDNF for neuroplasticity, and modulates neurotransmitter systems for balanced mood and focus. It's about removing barriers to peak cognitive function.

Dihexa builds new infrastructure. It promotes the physical formation of new synaptic connections — the hardware of cognition. It's about expanding the brain's capacity for information processing and memory storage.

This makes them complementary rather than competitive. Selank clears the noise; Dihexa strengthens the signal.

Practical Considerations

If anxiety impairs your research subjects' cognitive performance

Selank's anxiolytic properties make it the better starting point. Its rapid onset via nasal spray provides fast feedback on efficacy.

If the research question is about structural neuroplasticity

Dihexa's mechanism — physically promoting new synapses — is more directly relevant. Its oral route simplifies long-term protocol compliance.

If studying both pathways

The two peptides operate through independent mechanisms (GABA/BDNF vs. HGF/c-Met) and different routes of administration, making them feasible to study in combination without receptor competition.

Key Takeaway

Selank and Dihexa represent two distinct philosophies in cognitive peptide research: optimizing neurotransmitter balance versus building new neural connections. Understanding their mechanisms helps researchers choose the right tool — or the right combination — for their specific cognitive research questions.